Nevro (NYSE:NVRO – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, August 6th. Analysts expect Nevro to post earnings of ($0.63) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.
Nevro (NYSE:NVRO – Get Free Report) last announced its earnings results on Tuesday, May 7th. The medical equipment provider reported ($0.70) EPS for the quarter, topping the consensus estimate of ($1.02) by $0.32. Nevro had a negative return on equity of 27.48% and a negative net margin of 19.17%. The firm had revenue of $101.90 million for the quarter, compared to analysts’ expectations of $97.90 million. During the same quarter in the previous year, the company earned ($0.98) earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. On average, analysts expect Nevro to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Nevro Price Performance
Shares of NYSE:NVRO opened at $9.05 on Monday. Nevro has a 12 month low of $7.46 and a 12 month high of $22.64. The stock has a market cap of $332.41 million, a price-to-earnings ratio of -3.95 and a beta of 0.91. The stock’s 50 day moving average price is $9.07 and its 200 day moving average price is $12.29. The company has a debt-to-equity ratio of 0.77, a current ratio of 7.38 and a quick ratio of 5.57.
Wall Street Analyst Weigh In
Read Our Latest Analysis on Nevro
Nevro Company Profile
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems.
Featured Articles
- Five stocks we like better than Nevro
- Stock Sentiment Analysis: How it Works
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Nevro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nevro and related companies with MarketBeat.com's FREE daily email newsletter.